Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Revenue

Blueprint Medicines had revenue of $128.18M in the quarter ending September 30, 2024, with 126.61% growth. This brings the company's revenue in the last twelve months to $434.42M, up 100.93% year-over-year. In the year 2023, Blueprint Medicines had annual revenue of $249.38M with 22.22% growth.

• Revenue (ttm): $434.42M
• Revenue Growth: +100.93%
• P/S Ratio: 13.83
• Revenue / Employee: $663,229
• Employees: 655
• Market Cap: 6.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	249.38M	45.34M	22.22%
Dec 31, 2022	204.04M	23.96M	13.30%
Dec 31, 2021	180.08M	-613.66M	-77.31%
Dec 31, 2020	793.74M	727.22M	1,093.37%
Dec 31, 2019	66.51M	21.99M	49.39%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.